clinical trials
Standing together: Supercharging the clinical trial in Europe
September 18, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, clinical trials, drugs, pharma, pharmaceutical
The European Medicines Agency is on the cusp of rolling out one of the most ground-breaking digital platforms for facilitating …
Research into clinical trial transparency shows huge variation in standards
July 28, 2017Medical Communications, Sales and Marketing Abbott, GSK, biotech, clinical trials, drugs, pharma, pharmaceutical, transparency
A study published in the BMJ displayed the large degree of variation and lack of industry-standard when it comes to …
EMA reveals new clinical trial guidelines to reduce patient risk
July 28, 2017Medical Communications, Research and Development EMA, biotech, clinical trials, drugs, pharma, pharmaceutical
The EMA has announced its intention to introduce revised guidelines concerning the use of medicines in first in-human clinical trials …
Trials and Tribulations: The impact of new clinical trial regulation in Europe
April 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, clinical trials, regulations
The clinical trial is the fulcrum on which drug development and treatment hinges. Even with the advent of new technologies …
Three quarters of healthcare companies to invest in big data by 2021
February 9, 2017Medical Communications, Research and Development Big Data, analytics, clinical trials
The latest research by GBI Research suggests that there may be shift towards the use of big data and analytics …
Researchers financed by pharma more likely to produce positive results, new report says
January 18, 2017Research and Development clinical trials
A new paper published in the British Medical Journal (BMJ) has called the integrity of certain clinical trials into question …
Clinical trials and their patients: The rising costs and how to stem the loss
November 3, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials
The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …
MSD’s Alzheimer’s study could break new ground for treatment
November 3, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, MSD, clinical trials
MSD, known as Merck in North America, has published results of a Phase I trial of verubecestat. The drug is …
Pfizer surprises industry by ending development of projected blockbuster
November 1, 2016Research and Development Pfizer, cholesterol, clinical trials
Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …
FDA approves clinical trial of Cuban lung cancer vaccine
November 1, 2016Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials
The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …
Woodley Equipment Company Exhibiting at Partnerships in Clinical Trials Europe 2016
November 1, 2016PCT, clinical trials
Woodley Equipment Company is exhibiting at Partnerships in Clinical Trials Europe
AstraZeneca’s head and neck cancer treatment clinical trials put on hold
October 31, 2016Sales and Marketing AstraZeneca, clinical hold, clinical trials, immunotherapy, phase III
AstraZeneca, the Cambridge-based British company, had recruitment for its final stage Phase III trials placed on partial hold. The drug …
EMA opens clinical trial data to public
October 25, 2016Manufacturing and Production Amgen, AstraZeneca, EMA, EU, Kyprolis, clinical reports, clinical trials
The European Medicine Agency has begun to release to the public data on clinical trial via their own website. The …
Gilead’s drug boosted by positive Phase II trials and aims to move forward
October 21, 2016Medical Communications Gilead, Gilead Sciences, clinical trials, fatty liver disease
Gilead Sciences has announced positive results from three Phase II studies upon their drug GS-4997, otherwise known as selonsertib. The …
FDA grants $23 million to boost research on rare diseases
October 19, 2016Research and Development Cancer, FDA, clinical trials, oncology
The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …
Latest content
Five Facts about cardiovascular disease
